Yüklüyor......
Sphenopalatine ganglion block for refractory COVID-19 headache: a descriptive case series
Coronavirus SARS-CoV-2 is responsible for the COVID-19 pandemic, and headache is reported in 6.5% to 34% of all cases. There is little published evidence on the pharmacological treatment of COVID-19 headache. This case series presents six COVID-19 infected patients with refractory headache in which...
Kaydedildi:
| Yayımlandı: | Braz J Anesthesiol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8080502/ https://ncbi.nlm.nih.gov/pubmed/33932392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjane.2021.04.024 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|